These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16563669)

  • 1. The safety of tibolone in epithelial ovarian cancer patients.
    Lee KB; Lee JM; Yoon JH; Park CY
    Maturitas; 2006 Sep; 55(2):156-61. PubMed ID: 16563669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial cancer patients and tibolone: a matched case-control study.
    Lee KB; Lee JM; Lee JK; Cho CH
    Maturitas; 2006 Oct; 55(3):264-9. PubMed ID: 16678984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tibolone therapy in breast cancer survivors: a retrospective study.
    Goutzioulis M; Vavilis D; Agorastos T; Konstantinidis T; Pantazis K; Goutzioulis A; Goulis DG; Makedos G; Bontis JN
    J Obstet Gynaecol Res; 2007 Feb; 33(1):68-73. PubMed ID: 17212669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compliance to clinical guidelines for early-stage epithelial ovarian cancer in relation to patient outcome.
    Sijmons EA; van Lankveld MA; Witteveen PO; Peeters PH; Koot VC; van Leeuwen JS
    Eur J Obstet Gynecol Reprod Biol; 2007 Apr; 131(2):203-8. PubMed ID: 16707204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.
    Park JY; Seo SS; Kang S; Lee KB; Lim SY; Choi HS; Park SY
    Gynecol Oncol; 2006 Dec; 103(3):977-84. PubMed ID: 16837030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.
    Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Poynor EA; Aghajanian C; Jarnagin WR; DeMatteo RP; D'Angelica MI; Barakat RR; Chi DS
    Gynecol Oncol; 2006 Dec; 103(3):1083-90. PubMed ID: 16890277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer.
    Dimitrakakis C; Keramopoulos D; Vourli G; Gaki V; Bredakis N; Keramopoulos A
    Climacteric; 2005 Dec; 8(4):342-51. PubMed ID: 16390769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety of postoperative hormone replacement therapy in epithelial ovarian cancer patients in China.
    Wen Y; Huang H; Huang H; Wu M; Shen K; Pan L
    Climacteric; 2013 Dec; 16(6):673-81. PubMed ID: 23710587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tibolone on breast cancer cell proliferation in postmenopausal ER+ patients: results from STEM trial.
    Kubista E; Planellas Gomez JV; Dowsett M; Foidart JM; Pohlodek K; Serreyn R; Nechushkin M; Manikhas AG; Semiglazov VF; Hageluken CC; Singer CF
    Clin Cancer Res; 2007 Jul; 13(14):4185-90. PubMed ID: 17634547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy.
    Juretzka MM; Barakat RR; Chi DS; Iasonos A; Dupont J; Abu-Rustum NR; Poynor EA; Aghajanian C; Spriggs D; Hensley ML; Sabbatini P
    Gynecol Oncol; 2007 Jan; 104(1):176-80. PubMed ID: 16996584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma.
    Chi DS; McCaughty K; Diaz JP; Huh J; Schwabenbauer S; Hummer AJ; Venkatraman ES; Aghajanian C; Sonoda Y; Abu-Rustum NR; Barakat RR
    Cancer; 2006 May; 106(9):1933-9. PubMed ID: 16572412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only?
    Cliby WA; Aletti GD; Wilson TO; Podratz KC
    Gynecol Oncol; 2006 Dec; 103(3):797-801. PubMed ID: 17052746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of free plasma DNA before and after chemotherapy in patients with advanced epithelial ovarian cancer.
    Capizzi E; Gabusi E; Grigioni AD; De Iaco P; Rosati M; Zamagni C; Fiorentino M
    Diagn Mol Pathol; 2008 Mar; 17(1):34-8. PubMed ID: 18303408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral microvessel density in advanced epithelial ovarian cancer and its use as a prognostic variable.
    Gadducci A; Ferrero A; Cosio S; Zola P; Viacava P; Dompé D; Fanelli G; Ravarino N; Motta M; Cristofani R; Genazzani AR
    Anticancer Res; 2006; 26(5B):3925-32. PubMed ID: 17094423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized phase III trial of topotecan following carboplatin and paclitaxel in first-line treatment of advanced ovarian cancer: a gynecologic cancer intergroup trial of the AGO-OVAR and GINECO.
    Pfisterer J; Weber B; Reuss A; Kimmig R; du Bois A; Wagner U; Bourgeois H; Meier W; Costa S; Blohmer JU; Lortholary A; Olbricht S; Stähle A; Jackisch C; Hardy-Bessard AC; Möbus V; Quaas J; Richter B; Schröder W; Geay JF; Lück HJ; Kuhn W; Meden H; Nitz U; Pujade-Lauraine E; ;
    J Natl Cancer Inst; 2006 Aug; 98(15):1036-45. PubMed ID: 16882940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of salvage cytoreductive surgery in the treatment of patients with recurrent ovarian cancer after platinum-based chemotherapy.
    Matsumoto A; Higuchi T; Yura S; Mandai M; Kariya M; Takakura K; Fujii S
    J Obstet Gynaecol Res; 2006 Dec; 32(6):580-7. PubMed ID: 17100820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment.
    Cho H; Hur HW; Kim SW; Kim SH; Kim JH; Kim YT; Lee K
    Cancer Immunol Immunother; 2009 Jan; 58(1):15-23. PubMed ID: 18414853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of serum CA125 levels in patients with high-risk, early stage epithelial ovarian cancer.
    Kang WD; Choi HS; Kim SM
    Gynecol Oncol; 2010 Jan; 116(1):57-60. PubMed ID: 19818996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
    Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
    Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of therapeutic efficacy between TP regimen and CBP regimen on epithelial ovarian cancer after optimal cytoreductive operation].
    Gao KF; Liu FY; Chen FJ; Feng YL
    Ai Zheng; 2007 Apr; 26(4):431-4. PubMed ID: 17430668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.